Repeat calcium and kidney function within 24 to 72 hours when mild
Endocrinology or primary care follow up for PTH evaluation
Return now
Confusion or severe sleepiness
Fainting or palpitations
Severe vomiting or inability to keep fluids down
Severe weakness or inability to walk
Little or no urine output
New severe abdominal pain
References
Clinical guidelines and consensus
Key guidance sources
Endocrine Society Clinical Practice Guideline for Treatment of Hypercalcemia of Malignancy in Adults
Recommendations for IV bisphosphonate or denosumab
Recommendation for calcitonin combination in severe hypercalcemia of malignancy
Emergency guidance for acute hypercalcaemia in adults from endocrine specialty societies
Initial management with isotonic fluids
Use of IV bisphosphonate and calcitonin in severe cases
Institutional inpatient algorithms for acute hypercalcemia management
Fluid bolus then infusion strategy
Monitoring guidance for fluid overload risk
Evidence based sources
Supporting evidence examples
Randomized trial evidence comparing zoledronic acid versus pamidronate for hypercalcemia of malignancy
Systematic review supporting Endocrine Society hypercalcemia of malignancy guideline
Review evidence on limitations of albumin corrected calcium formulas in hypoalbuminemia
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.